Loss of tolerance to glycoprotein 2 isoforms 1 and 4 is associated with Crohn's disease of the pouch.

Donelle CummingsMichael CruiseRocio LopezDirk RoggenbuckVipul JairathYinghong WangBo ShenFlorian Rieders

Published in: Alimentary pharmacology & therapeutics (2018)

The novel anti-GP21 and GP24 antibodies are associated with Crohn's disease of the pouch in ulcerative colitis patients after IPAA. Serological anti-GP2 antibodies could aid in diagnosis of Crohn's disease of the pouch.

Keyphrases

end stage renal disease
ulcerative colitis
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes